PharmaLectures.com

Courses › Pharma training by role › Owner, CEO and board: working with European counterparts, minus the friction

Owner, CEO and board: working with European counterparts, minus the friction

Your board approves European deals and filings in one meeting, not three.

  • 6 audio modulesthree lengths each
  • 1 h to 5 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Owner, CEO and boardwho it is written for

Why this training matters

The board meets on a European acquisition, and nobody can say when the German Works Council must be consulted. The vote slips, the seller's lock-in period runs out and a rival bid arrives. Meanwhile your regulatory team waits on a signature for a centralised marketing authorisation application.

What changes after this course

Your directors ask the Works Council, competition and filing questions before the meeting, not after the vote. Each module ends with a recorded multiple-choice questionnaire. You hold a certificate per learner and a training record for each person in your files.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your executive team stops second-guessing regulatory strategy before a European launch. A director reads feedback from the European Medicines Agency and knows whether the application runs through the centralised procedure or through national authorities. Questions about Good Manufacturing Practice get an answer in the meeting, not after a month of emails.

Board papers on European expansion reach the table with the governance question already answered. Directors see whether national law requires a supervisory board above a management board, and they ask the right thing before the lawyers are called. When a European annual report lands, the audit committee checks it against International Financial Reporting Standards and the local accounting rules.

A restructuring plan for a German site no longer surprises the Works Council. Your deal team allows for Works Council consultation in the acquisition timetable at the start. The same team shapes the terms so the European Commission competition review clears, and the labour risks of the target site are found before signing.

Product plans line up with Directive 2001/83/EC for medicinal products and Regulation (EU) 2017/745 for medical devices from the first planning meeting. Redesigns drop away, because your leadership asks the legal question before the design is frozen. Submissions reach the national authority in the form it expects.

Who needs this training

  • Chief Executive Officer

    Board debates drift into questions about European market entry rules. You close them with the governance and regulatory frameworks already in your head, and the vote moves forward in the same meeting.

  • Board Member

    You vote on a European expansion plan and need to know whether local governance, labour law or reporting rules expose the parent company. You ask the right question while the paper is still on the table.

  • Chief Financial Officer

    Month-end close stalls while European subsidiary statements are reconciled to group policy. Your team applies International Financial Reporting Standards correctly the first time, and the audit committee receives numbers it can check.

  • Head of Mergers and Acquisitions

    You run a European deal with a seller's deadline ticking. Works Council consultation and European Commission competition review both sit on your timetable, and you plan for them before the first draft of terms.

Roles: Owner, CEO and board

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Name the route, centralised or national, that a given marketing authorisation application takes, and which decision the board must make to keep it moving.
  2. Describe which duties belong to the supervisory board and which to the management board under a two-tier national system.
  3. Match an article of Directive 2001/83/EC to the product launch step it controls.
  4. Check a European subsidiary's statements against International Financial Reporting Standards and flag what needs restating for group reporting.
  5. Place Works Council consultation steps into a restructuring schedule before the announcement date is set.
  6. Draft an acquisition timetable and terms that allow for European Commission competition review.
  7. Spot where the transition dates in Regulation (EU) 2017/745 change the order of your medical device projects.

What the company gets

  • Regulatory affairs gets board signatures in time for the application, because directors know which procedure the filing follows and who decides.
  • Directors come to the board vote on a European acquisition already knowing how Works Council consultation affects the timetable.
  • Audits of European subsidiaries run more smoothly when the group reporting packages arrive already reconciled to International Financial Reporting Standards.
  • Compliance files hold a certificate per learner and a training record for each person, ready when an auditor asks.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 6 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard2 h 30 min25 min a module, for regulatory, quality and business-development staff
Expanded5 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing1 h

Course outline: 6 modules

6 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Send European Medicines Agency and national filings through without delay

    • Why a centralised application stalls at the European Medicines Agency, and which decision frees it.
    • The national authority contact your team calls first, so no question waits in the wrong inbox.
    • What to do when a national authority questions your Good Manufacturing Practice during an inspection.
  2. 2Set up supervisory and management boards that pass legal scrutiny

    • How to split power between supervisory and management boards where national law demands two tiers.
    • The oversight duties that bind a foreign Chief Executive Officer running a European subsidiary.
    • Why a strategic vote can fail in the boardroom before it starts, and the habit that prevents it.
  3. 3Apply Directive 2001/83/EC and Regulation (EU) 2017/745 to product strategy

    • Which articles of Directive 2001/83/EC decide how you may market a medicinal product in Europe.
    • How the transition dates in Regulation (EU) 2017/745 set the order of your medical device projects.
    • What happens to your team when the penalty rules for breaking pharmaceutical law are ignored.
  4. 4Check European reports against International Financial Reporting Standards

    • How International Financial Reporting Standards turn subsidiary profit into the group figure you report.
    • The checks your audit committee runs on a European annual report before the board signs it.
    • When a subsidiary statement follows local accounting rules and when it must be restated for the group.
  5. 5Agree operational changes with Works Councils before a strike forms

    • What consultation rights a German Works Council holds when you plan to restructure a site.
    • How a collective bargaining agreement limits the changes your managers can order on the shop floor.
    • What to do when national labour rules clash with a global human resources policy.
  6. 6Close European acquisitions that clear European Commission competition review

    • How to structure a European merger so the European Commission competition review does not stall it.
    • The labour risks your due diligence team finds before you buy a European pharmaceutical site.
    • What a cultural misread at the negotiating table costs in deal terms, and how to avoid it.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

6 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h in the briefing length and 5 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Owner, CEO and board. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 54 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team